purmorphamine drug
Evidence from:
primary |
all sources
Related entities (3)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| purmorphamine | associated_with | B-27 supplement | — | 1 |
| purmorphamine | targets | midbrain | — | 1 |
| purmorphamine | associated_with | N2 medium | — | 1 |
Mentioned in (7)
Papers in which this entity is mentioned.
- Human 3D brain organoids: steering the demolecularization of brain and neurological diseases. (2023)
- FXR1 regulation of parvalbumin interneurons in the prefrontal cortex is critical for schizophrenia-like behaviors. (2021)
- Preaxial polydactyly following early gestational exposure to the smoothened agonist, SAG, in C57BL/6J mice. (2017)
- Single-Cell Profiling of an In Vitro Model of Human Interneuron Development Reveals Temporal Dynamics of Cell Type Production and Maturation. (2017)
- Smoothened determines β-arrestin-mediated removal of the G protein-coupled receptor Gpr161 from the primary cilium. (2016)
- Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. (2011)
- Activation of heterotrimeric G proteins by Smoothened. (2006)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| purmorphamine | drug | 7 | 13 |